Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022

Since March 2022, there has been an emergence of multidrug-resistant organisms (MDRO) in the Netherlands in patients originating from Ukraine (58 patients, 75 isolates). For about half of these patients, recent hospitalisation in Ukraine was reported. Genomic surveillance revealed that the majority...

Descripción completa

Detalles Bibliográficos
Autores principales: Zwittink, Romy D, Wielders, Cornelia CH, Notermans, Daan W, Verkaik, Nelianne J, Schoffelen, Annelot F, Witteveen, Sandra, Ganesh, Varisha A, de Haan, Angela, Bos, Jeroen, Bakker, Jacinta, Schneeberger-van der Linden, Caroline, Kuijper, Ed J, de Greeff, Sabine C, Hendrickx, Antoni PA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808315/
https://www.ncbi.nlm.nih.gov/pubmed/36695467
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.50.2200896
Descripción
Sumario:Since March 2022, there has been an emergence of multidrug-resistant organisms (MDRO) in the Netherlands in patients originating from Ukraine (58 patients, 75 isolates). For about half of these patients, recent hospitalisation in Ukraine was reported. Genomic surveillance revealed that the majority of the MDRO represent globally spread epidemic lineages and that 60% contain New Delhi metallo-β-lactamase (NDM) genes. Professionals should be aware of an increase in such MDRO associated with migration and medical evacuation of people from Ukraine.

Ejemplares similares